Search
for
Sort by
Research 181–210 of 1000+
- An evidence based case report of alopecia areata treated with individualised homoeopathic medicine
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- A randomized trial of minoxidil in chemotherapy-induced alopecia
- Cutaneous reactions to recombinant cytokine therapy
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Assessment of the obese patient
- Oral Manifestations of Hematologic and Nutritional Diseases
- Cutaneous Manifestations of Eating Disorders
- Effect of minoxidil on blood pressure and hemodynamics in severe hypertension
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss
- COVID‐19, androgens, and androgenic alopecia
- The Charnoly body as a universal biomarker of cell injury
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Management of Toxicities of Targeted Therapies
- Dermatology and Pregnancy
- Lipid nanocarriers as innovative strategies for hair regrowth
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Physiological dermatological changes during pregnancy: literature review
- EFFICACY AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN THE TREATMENT OF ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Lichen Planopilaris
- Acitretin for the Treatment of Psoriasis: A Case Report of Long-Lasting Alopecia
- Aldesleukin
- Alopecias
- Drugs that affect autonomic functions or the extrapyramidal system
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME